Catalyst Biosciences Funding & Investors
South San Francisco, CA
Catalyst Biosciences, Inc. operates as a biopharmaceutical company. The Company develops novel medicines to address hematology indications, as well as deals in treatment of hemophilia and surgical bleeding. Catalyst Biosciences serves patients in the United States.
catalystbiosciences.comTotal Amount Raised: $301,314,496
Catalyst Biosciences Funding Rounds
Post Ipo Equity
$50,000,000
Post Ipo Debt
$1,000,000
Post Ipo Equity
$3,224,993
Post Ipo Equity
$5,009,841
Post Ipo Equity
$400,004
Post Ipo Equity
$5,072,000
Post Ipo Equity Investors
Novartis Venture FundJohnson & Johnson DevelopmentBurrill & CompanyHealthcare VenturesMorgenthalerEssex WoodlandsPost Ipo Equity
$13,407,658
Post Ipo Equity Investors
Johnson & Johnson DevelopmentBurrill & CompanySofinnovaMorgenthalerEssex WoodlandsPost Ipo Equity
$7,000,000
Post Ipo Equity
$40,000,000
Post Ipo Equity Investors
Novartis Venture FundJohnson & Johnson DevelopmentBurrill & CompanyHealthcare VenturesSofinnovaMorgenthalerEssex WoodlandsSeries B
$30,000,000
Series B Investors
Novartis Venture FundBurrill & CompanyRCT BioVenturesHealthcare VenturesSofinnovaMorgenthalerIPO
Unknown
Series A
$10,200,000
Series A Investors
RCT BioVenturesSofinnovaSeries Unknown
$60,000,000
Series Unknown Investors
Cogene VenturesOxford Bioscience PartnersJafco Life ScienceBison CapitalCastle Rock InnovationsSeries Unknown
$46,000,000
Series Unknown Investors
Burrill & CompanyAdvent Venture PartnersNew Enterprise Associates (NEA)Academy Venture FundCDIB BioScience VenturesNomura InternationalGenaventCDC IXIS InnovationEaston Capital Investment GroupSociete Generale Asset ManagementEuclidSR PartnersAuriga PartnersSeries Unknown
$30,000,000
Funding info provided by Diffbot.